Rheumatology Symposium Speakers

17rheumlogo

Friday, September 22, 2017
Courtyard Marriott • Columbia, MO

InformationAgendaHandoutsLive Stream •  Speakers
Accreditation • Location/Lodging • Exhibitors
gold-bar

rheum17jbusselJames Bussel, MD

James Bussel is the Director of the Platelet Disorders Program at Weill Medical College of Cornell University, focusing on understanding the pathophysiology of, and improved treatments for, thrombocytopenia, particularly ITP. Due to his work on platelet disorders and the advances in treatment, Dr Bussel is a nationally and internationally renowned educator and recognized leader in clinical research trials in ITP.  He has performed seminal studies in the management of low platelets including important work with all commonly used treatments of ITP such as IVIG, rituximab, and the TPO agents. He developed the first successful management programme for fetuses with low platelet counts caused by fetal alloimmune thrombocytopenia, which led to Dr Bussel being awarded the King Faisal International Prize in Medicine for 2012. Known as the Arab Nobel Prize, it is awarded to “men and women who have made truly outstanding contributions in their respective fields”; Dr Bussel, along with a colleague at Columbia, received this award for over 30 years of research developing non-invasive treatments for this disorder.  Dr Bussel attended Yale University as an undergraduate and Columbia University College for Physicians & Surgeons, and received his training at Children’s Hospital Medical Center, Cincinnati, Memorial Sloan-Kettering Cancer Center and the New York Hospital-Cornell Medical Center. Dr Bussel holds Board Certifications in Pediatrics and Pediatric Hematology-Oncology and holds secondary appointments in the Departments of Medicine and OB-GYN. His clinical interests are ITP, platelet disorders and immunohematology; and also bleeding disorders and immune deficiency diseases. Dr Bussel has published more than 200 articles, including six original articles in the New England Journal of Medicine and six in the Lancet.


rheum17cronRandy Cron, MD, PhD

Dr. Cron received his MD from UCLA, and completed his Pediatric Residency at Stanford, and Pediatric Rheumatology Fellowship at the University of Washington. After completing post-doctoral training at Stanford, Dr. Cron held his first faculty appointment at the University of Pennsylvania/Children’s Hospital of Philadelphia until being recruited in 2007 to the University of Alabama at Birmingham (UAB) to start a Pediatric Rheumatology division. Professor Cron serves as the Arthritis Foundation, Alabama Chapter Endowed Chair and Division Director of Pediatric Rheumatology at UAB. He also developed and serves as the Program Director of the Pediatric Rheumatology Fellowship Program at UAB. He has grown his division from zero to 5 physician-scientists and 3 pediatric nurse practitioners, the largest Pediatric Rheumatology program in the Southeastern United States. Dr. Cron also has a PhD in Immunology from the University of Chicago, and his laboratory’s basic research focuses on transcriptional regulation in CD4 T lymphocytes as it relates to both systemic lupus erythematosus (SLE) and HIV-1/AIDS. His clinical and translational research interests include childhood arthritis related macrophage activation syndrome (MAS) and temporomandibular joint (TMJ) arthritis, for both of which he is known world-wide.


rheum17dyer-webJon A. Dyer, MD

Dr. Dyer is Associate Professor of Dermatology and Director of Pediatric Dermatology at the University of Missouri.  He is board certified in Pediatric Dermatology.  His clinical and research interests include pediatric dermatology, inherited skin diseases, cutaneous mosaicism, pediatric teledermatology, birthmarks and severe atopic dermatitis.  Dr. Dyer graduated medical school and completed a residency at the University of Missouri, and completed a pediatric dermatology Fellowship at Northwestern University, Childrens Memorial Hospital in Chicago.


rheum17knutsonAlan Knutsen, MD

Dr. Knutsen cares for children and adults with primary immunodeficiency disorders, as well as children with acquired immunodeficiency diseases, such as HIV.  In addition, Dr. Knutsen treats allergic conditions, including asthma, allergic rhinitis, allergic conjunctivitis, food allergy, drug allergy, insect allergy, anaphylaxis, sinusitis and fungal sinusitis. He has a special interest in fungal allergies, asthma, and allergic bronchopulmonary aspergillosis (ABPA).  Dr. Knutsen is involved in research studies for primary immunodeficiency disorders, fungal sensitivity in  severe asthma, ABPA, treatment of severe asthma, and long-term surveillance of HIV-exposed and infected children in the St. Louis area.   He is a professor in the Department of Pediatrics, Division of Allergy and Immunology, at Saint Louis University School of Medicine.  Dr. Knutsen is an active member of the American Academy of Asthma, Allergy and Immunology, Clinical Immunologic Society, and American College of Allergy Asthma and Immunology.


rheum17marshallGary Marshall, MD

A native of Philadelphia, Dr. Marshall received his undergraduate degree from the University of Pennsylvania and his medical degree from Vanderbilt University. After completing a pediatric residency at Vanderbilt in 1986, he entered a fellowship in infectious diseases at the Children’s Hospital of Philadelphia. In 1989, he joined the Department of Pediatrics at the University of Louisville School of Medicine, where he is now Professor of Pediatrics, Chief of the Division of Pediatric Infectious Diseases, and Director of the Pediatric Clinical Trials Unit. Dr. Marshall also serves as an attending physician at Kosair Children’s Hospital and sees patients in the infectious diseases clinic. During his tenure in Louisville, he has been recognized as an astute clinician/educator, a productive investigator, and an effective administrator. He has received the Outstanding Clinical Professor Award, Educator of the Year Award, and the Peer Clinician-Teacher Excellence Award from the Department of Pediatrics, as well as the Distinguished Educator Award from the School of Medicine and the Educational Achievement Award from the Kentucky Medical Association. In addition, under Dr. Marshall’s leadership the pediatric residents have repeatedly recognized the Division of Pediatric Infectious Diseases for excellence in teaching and patient care. Dr. Marshall is a member of the Society for Pediatric Research and the Pediatric Infectious Diseases Society and has served in several national leadership positions. He has authored over 150 papers and is best known for his work in vaccine development, advocacy, and education. He is also the author of The Vaccine Handbook: A Practical Guide for Clinicians (The Purple Book), now in its 5th edition and available through an app for iOS devices.


rheum17ozenSeza Ozen, MD

Dr Seza Özen is Professor and Head of the Department of Paediatric Rheumatology at Hacettepe University Faculty of Medicine, Ankara, Turkey.  She completed her Pediatrics residency in Hacettepe University Dept. of Pediatrics in 1989. She was a post-doctoral research fellow: Stanford University Medical Center, Stanford, California, USA in 1989-1991 (Research Subject: Critical residues in the allorecognition of HLA-B27). She has been Faculty in Department of Pediatrics, Hacettepe University since then.  Dr Seza Özen was the Chair for Pediatric Rheumatology at “European League against Rheumatism” (EULAR) between the years 2003-2007 and is now an Honorary Member of EULAR. She has served as the President for the International Society of Autoinflammatory Syndromes (ISSAID) between 2013 to 2016.  Dr Özen was the Principle Investigator (PI) of three EULAR endorsed international projects on vasculitis and Familial Mediterranean fever (FMF). She has received numerous grants (as Principle Investigator) form the scientific and technical councils of the country and has participated in many national and international studies. She is currently on the editorial board of four Pediatric and/or Rheumatology journals.  Dr Seza Özen has published 373 articles in SCI journals with 10 361 citations (h factor 52).  Main interests of Dr Seza Ozen are vasculitis and FMF and the autoinflammatory diseases. She has lectured in many meetings and universities around the globe on these subjects and has written chapters in textbooks.